Back to search
FDAFDA · Food and drugs·Recall number Z-1251-2017

URF-P6 Uretero-reno fiberscope and URF-P6R Uretero-reno fiberscope

Published March 8, 2017 · Recall initiated: December 12, 2016

Summary

FDA records medical device Class II recall Z-1251-2017, published March 8, 2017 and initiated December 12, 2016. Recalling firm: Olympus Corporation of the Americas; Status: Terminated; Reported quantity: 3461 units distributed to US consignees; Lot: All serial numbers are affected. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Olympus is recalling the URF-P6/P6R endoscopes due to a similar device (URF-V2/V2R endoscopes) but not identical, where adverse event complaints associated with tissue trauma, perforation and insertion tubes which were stuck inside of patients that had to be surgically removed. In an effort to mitigate a potential risk to patient health, Olympus is undertaking this action to notify users of these complaints and the need for careful inspection of the endoscope prior to use in accordance with the instructions provided int heir notification letter.

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Olympus Corporation of the Americas
Distributor
Distributed Nationwide
Lot
All serial numbers are affected.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was URF-P6 Uretero-reno fiberscope and URF-P6R Uretero-reno fiberscope recalled?

Yes. FDA published recall Z-1251-2017 on March 8, 2017. Reported hazard: Olympus is recalling the URF-P6/P6R endoscopes due to a similar device (URF-V2/V2R endoscopes) but not identical, where adverse event complaints associated with tissue trauma, perforation and insertion tubes which were stuck inside of patients that had to be surgically removed. In an effort to mitigate a potential risk to patient health, Olympus is undertaking this action to notify users of these complaints and the need for careful inspection of the endoscope prior to use in accordance with the instructions provided int heir notification letter.

What should I do if I have this product?

Voluntary: Firm initiated